Avascular Osteonecrosis and Accompanying Anemia, Leucocytosis, and Decreased Bone Mineral Density in Renal Transplant Recipients

被引:8
|
作者
Paydas, S. [1 ]
Balal, M. [1 ]
Demir, E. [2 ]
Sertdemir, Y. [3 ]
Erken, U. [2 ]
机构
[1] Cukurova Univ, Dept Nephrol, Fac Med, TR-01330 Adana, Turkey
[2] Cukurova Univ, Dept Urol, Fac Med, TR-01330 Adana, Turkey
[3] Cukurova Univ, Dept Biostat, Fac Med, TR-01330 Adana, Turkey
关键词
FEMORAL-HEAD; ALLOGRAFT RECIPIENTS; NECROSIS; HIP;
D O I
10.1016/j.transproceed.2011.02.072
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Avascular osteonecrosis (AVN) is a complication of renal transplantation. In this study, we present 12 cases of AVN associated with renal transplantation. Methods. Renal transplant recipients (RTRs) with AVN (group I [GI]) were evaluated by using magnetic resonance imaging and blood urea nitrogen, creatinine, glucose, calcium, phosphorus, magnesium, alkaline phosphatase, parathyroid hormone, and urine analysis. We evaluated bone mineral density (BMD) of the femoral neck and lumbar vertebrae. All patients were treated with steroids, cyclosporine, or tacrolimus plus mycophenolate mofetil. Twenty-six RTRs (GII) without AVN were randomly selected as control subjects. Results. The mean ages of GI and GII, were 33.81 +/- 6.72 and 34.00 +/- 7.65 years respectively (P > .05). The mean interval between transplantation and development of AVN was 12.08 +/- 6.48 months. Although levels of blood urea nitrogen, creatinine, calcium, magnesium, and parathyroidhormone, as well as glucocorticoid doses in the first 12 months were similar in GI and GII, there were significant differences in serum alkaline phosphatase, hemoglobin levels, and white blood cell count between GI and GII (P < .05 for each). BMD T score <-1.5 was observed in 8/9 GI and 15/26 patients in GII. All of the patients with AVN except 1, were followed with conservative measures including calcium, magnesium, and vitamin D replacement therapies, bisphosphonate, and reduced or ceased glucocorticoid treatment. Although T scores of the femoral head were similar in GI and GII, the lumbar vertebral T score was significantly lower in GI than in GII (P < .052). Conclusion. AVN developed within the first year after transplantation. Decreased lumbar vertebral BMD, which can be an indicator of glucocorticoid effect, accompanied AVN in nearly all patients. Despite the absence of renal dysfunction, increased bone destruction, anemia, and leucocytosis were coincidental or accompanying findings in our patients with AVN.
引用
收藏
页码:863 / 866
页数:4
相关论文
共 50 条
  • [1] AVASCULAR OSTEONECROSIS (AON) IN RENAL-TRANSPLANT RECIPIENTS
    CALADO, J
    COLACO, S
    RIBEIRO, F
    LOBOS, AV
    PATACA, I
    NOLASCO, F
    COSTA, AM
    PENA, JR
    KIDNEY INTERNATIONAL, 1994, 45 (01) : 290 - 291
  • [2] Is decreased bone mineral density in pediatric transplant recipients really a problem?
    Feber, J
    Filler, G
    Cochat, P
    PEDIATRIC TRANSPLANTATION, 2003, 7 (05) : 342 - 344
  • [3] Decreased bone mineral density in the pediatric renal transplant population
    Acott, PD
    Crocker, JFS
    Wong, JA
    PEDIATRIC TRANSPLANTATION, 2003, 7 (05) : 358 - 363
  • [4] Statin use and bone mineral density in renal transplant recipients
    Prasad, GVR
    Chiu, R
    Nash, MM
    Zaltzman, JS
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (10) : 1320 - 1321
  • [5] Effect of deflazacort on bone mineral density in renal transplant recipients
    Kim, MS
    Kim, YS
    Lim, SK
    Kim, SI
    Moon, JI
    Park, K
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3041 - 3042
  • [6] Bisphosphonates can improve bone mineral density in renal transplant recipients
    Ralf Westenfeld
    Vincent M Brandenburg
    Markus Ketteler
    Nature Clinical Practice Nephrology, 2006, 2 : 676 - 677
  • [7] Relationship between leptin and bone mineral density in renal transplant recipients
    Agras, PI
    Baskin, E
    Saatci, U
    Colak, T
    Cengiz, N
    Kinik, ST
    Isiklar, I
    Haberal, A
    Mert, I
    Haberal, M
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (07) : 3106 - 3108
  • [8] The correlation between sclerostin and bone mineral density in renal transplant recipients
    Coban, Melahat
    Okten, Sarper
    NEFROLOGIA, 2020, 40 (05): : 506 - 513
  • [9] Bisphosphonates can improve bone mineral density in renal transplant recipients
    Westenfeld, Ralf
    Brandenburg, Vincent M.
    Ketteler, Markus
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (12): : 676 - 677
  • [10] Bone mineral density in pediatric transplant recipients
    Daniels, MW
    Wilson, DM
    Paguntalan, HG
    Hoffman, AR
    Bachrach, LK
    TRANSPLANTATION, 2003, 76 (04) : 673 - 678